Johnson & Johnson recently released its COVID-19 vaccine trial data. CP3 Director Dr. Walid Gellad told Reuters Health, "The key is not only overall efficacy but specifically efficacy against severe disease, hospitalization, and death."
Johnson & Johnson recently released its COVID-19 vaccine trial data. CP3 Director Dr. Walid Gellad told Reuters Health, "The key is not only overall efficacy but specifically efficacy against severe disease, hospitalization, and death."